Skip to main content

Antifungal activities of origanum oil against Candida albicans


The antimicrobial properties of volatile aromatic oils from medicinal as well as other edible plants has been recognized since antiquity. Origanum oil, which is used as a food flavoring agent, possesses a broad spectrum of in vitro antimicrobial activities attributed to the high content of phenolic derivatives such as carvacrol and thymol. In the present study, antifungal properties of origanum oil were examined both in vitro and in vivo. Using Candida albicans in broth cultures and a micro dilution method, comparative efficacy of origanum oil, carvacrol, nystatin and amphotericin B were examined in vitro. Origanum oil at 0.25 mg/ml was found to completely inhibit the growth of C. albicans in culture. Growth inhibitions of 75% and >50% were observed at 0.125 mg/ml and 0.0625 mg/ml level, respectively. In addition, both the germination and the mycelial growth of C. albicans were found to be inhibited by origanum oil and carvacrol in a dose-dependent manner. Furthermore, the therapeutic efficacy of origanum oil was examined in an experimental murine systemic candidiasis model. Groups of mice (n = 6) infected with C. albicans (5 × LD50) were fed varying amounts of origanum oil in a final vol. of 0.1 ml of olive oil (vehicle). The daily administration of 8.6 mg of origanum oil in 100 μl of olive oil/kg body weight for 30 days resulted in 80% survivability, with no renal burden of C. albicans as opposed to the group of mice fed olive oil alone, who died within 10 days. Similar results were obtained with carvacrol. However, mice fed origanum oil exhibited cosmetically better clinical appearance compared to those cured with carvacrol. The results from our study encourage examination of the efficacy of origanum oil in other forms of systemic and superficial fungal infections and exploration of its broad spectrum effect against other pathogenic manifestations including malignancy.

This is a preview of subscription content, access via your institution.


  1. 1.

    Leung AY, Fostere S: Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics, 2nd Ed. New York, John Wiley & Sons, 1996, p 11

    Google Scholar 

  2. 2.

    Laredo JV, Abut M, Calvo-Torras MA: Antimicrobial activity of essences from Labiatae. Microbios 82: 171–762, 1995

    Google Scholar 

  3. 3.

    Knobloch K, Pauli A, Iberl N, Wqeigand N, Weis HM: Antibacterial and antifungal properties of essential oil components. J Essent Oil Res 1: 119–128, 1989

    Google Scholar 

  4. 4.

    Barrata MT, Dorman HJD, Deans SG, Biondi DM, Ruberro G: Chemical composition, antibacterial and antioxidative activity of laurel, sage, rosemary, oregano and coriander essential oils. J Essent Oil Res 10: 618–627, 1998

    Google Scholar 

  5. 5.

    Barrata MT, Dorman HJD, Deans SG, Biondi DM, Ruberro G: Antimicrobial antioxidant properties of some commercial essential oils. Flav Frag J 13: 235–244, 1998

    Google Scholar 

  6. 6.

    Lis-Balchin M, Deans SG: Bioactivity of selected plant essential oils against Listeria monocytogenes. J Appl Microbiol 82: 759–762, 1997

    Google Scholar 

  7. 7.

    Tantaoui-Elaraki A, Beraoud L: Inhibition of growth and aflatoxin production in Aspergillus parasiticus by essential oils of selected plant materials. J Environ Path Toxicol Oncol 13: 67–72, 1994

    Google Scholar 

  8. 8.

    Conner DE, Beuchat, LR: Effects of essential oils from plants on growth of food spoilage yeasts. J Food Sci 49: 429, 1984

    Google Scholar 

  9. 9.

    Llewellyn GC, Burkett ML, Eadie T: Potential mold growth, aflatoxin production and antimycotic activity of selected natural spices and herbs. Assoc Anal Chem 64: 955–962, 1981

    Google Scholar 

  10. 10.

    Adam K, Sivropoulou A, Kokkini S, Lanaras T, Arsenakis M: Antifungal activities of Origanum vulgare subsp. Hirusutum, Mentha spicata, Lavanula angustifolia, and Salvia fruticosa essential oils against human pathogenic fungi. J Agricul Food Chem 46: 1739–1745, 1998

    Google Scholar 

  11. 11.

    Kaufman HK: Opportunistic fungal infections: Superficial and systemic candidiasis. Geriatrics 52: 50–54, 1997

    Google Scholar 

  12. 12.

    Friedman S, Richardson SE, Jacobs SE, O'Brien K: Systemic infection in extremely low birth weight infants: Short term morbidity and neuro developmental outcome. Ped Infect Disease J 19: 499–504, 2000

    Google Scholar 

  13. 13.

    Young GL, Jewell D: Topical treatment for vaginal candidiasis in pregnancy. Cochrane Datab System Rev 2: CD000225, 2000

    Google Scholar 

  14. 14.

    Rippon JW: Candidiasis and the pathogenic yeasts. In: J.W. Rippon (ed), Med Mycol, PA, 1988, pp 532–581

  15. 15.

    Kennedy WA, Laurier C, Gautrin D, Ghezzo H, Pare MJL, Contandriopoulos AP: Occurrence of bad risk factors of oral candidiasis treated with oral antifungals in seniors using inhaled steroids. J Clin Epidem 53: 696–701, 2000

    Google Scholar 

  16. 16.

    Sallah S: Hepatosplenic candidiasis in patients with acute leukemia: Increasingly encountered complication. Anticancer Res 19: 757–760, 1999

    Google Scholar 

  17. 17.

    Jagarlamudi R, Kumar L: Systemic fungal infections in cancer patients. Trop Gastroenterol 21: 3–8, 2000

    Google Scholar 

  18. 18.

    Mackenzie DWR, Cauwenberg G, Van Cutsem J, Drouhet E, Dupont B: Mycoses in AIDS patients: An overview. In: H. Vanden Bossche (ed), Mycoses in AIDS Patients. New York, Plenum Press, 1990, p 27–33

    Google Scholar 

  19. 19.

    Shadomy S, Espinel-Ingroff: Susceptibility testing with antifungal Drugs. Manual Clin Microbiol 3, 1980

  20. 20.

    Rex JH, Pfaller MA, Galgiani JN, Bartlett MS, Espinel-Ingroff A, Ghannoum MA, Lancaster M, Odds FC, Rinaldi MG, Walsh TJ, Barry AL: Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for flucanozole and itraconazole, and Candida infections. Clin Infect Dis 24: 235–247, 1997

    Google Scholar 

  21. 21.

    Manohar V, Sirsi M, Ramananda Rao G: Yeasts in superficial mycoses I. Incidence, isolation and characterization. Indian J Med Res 63: 261–265, 1975

    Google Scholar 

  22. 22.

    Manohar V, Sirsi M, Ramananda Rao G: Yeasts in superficial mycosis II. Pathogenicity of Candida species to swiss albino mice. Indian J Med Res 64: 9–15, 1975

    Google Scholar 

  23. 23.

    Zava DT, Delban CM, Blan M: Estrogen and bioactivity of foods, herbs and spices. Proc Soc Exp Biol Med 217: 369–378, 1998

    Google Scholar 

  24. 24.

    Staib P, Kretschmar M, Nichterlein T, Hof H, Morschhauser J: Differential activation of a Candida albicans virulence gene family during infection. Proc Natl Acad Sci USA 97: 6102–6107, 2000

    Google Scholar 

  25. 25.

    Heinig MJ, Francis J, Pappagiansis D: Mammary candidosis in lactating women. J Hum Lact 15: 281–288, 1999

    Google Scholar 

  26. 26.

    Dorman HJ, Deans SG: Antimicrobial agents from plants: Antibacterial activity of plant volatile oils. J Appl Microbiol 88: 308–316, 2000

    Google Scholar 

  27. 27.

    Basilico MZ, Basilico JC: Inhibitory effects of some spice essential oils on Aspergillus ochraceus NRRL 3174 growth and ochratoxin A production. Lett Appl Microbiol 29: 238–241, 1999

    Google Scholar 

  28. 28.

    Van den Broucke CO, Lemli JA: Antispasmodic activity of Origanum compactum. Part 2: Antagonistic effects of thymol and carvacrol. Planta Med 45: 188–190, 1982

    Google Scholar 

  29. 29.

    Nakatani N: Phenolic antioxidants from herbs and spices. Biofactors 13: 141–146, 2000

    Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Harry G. Preuss.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Manohar, V., Ingram, C., Gray, J. et al. Antifungal activities of origanum oil against Candida albicans. Mol Cell Biochem 228, 111–117 (2001).

Download citation

  • antifungal activity
  • in vitro
  • in vivo
  • female BALB/c mice
  • origanum oil
  • Candida albicans
  • carvacrol
  • nystatin
  • amphotericin B